show that ATG5 deletion accelerates early oncogenesis, increasing the number of tumor foci and the transition from hyperplasia to adenomas; however as cancer develops, lack of ATG5 reduces the progression from adenoma to adenocarcinoma, resulting in a decrease of tumors mass and enhanced lifespan in mice (271). This evidence concerns the gene ATG5 and adenocarcinoma.